Cargando…
Taking cues from convalescence to improve vaccines against hepatitis C virus
Hepatitis C virus (HCV) infection remains a worldwide public health issue despite direct-acting antivirals. A substantial proportion of infected individuals (15%–45%) spontaneously clear repeated HCV infections with genetically different viruses by generating broadly neutralizing antibodies (bNAbs)....
Autores principales: | Sreekumar, Bharath K., Taha, Taha Y., Ott, Melanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337820/ https://www.ncbi.nlm.nih.gov/pubmed/35912856 http://dx.doi.org/10.1172/JCI161819 |
Ejemplares similares
-
Is a single COVID-19 vaccine dose enough in convalescents ?
por: Focosi, Daniele, et al.
Publicado: (2021) -
Convalescent plasma therapy for persistent hepatitis E virus infection
por: Ankcorn, Michael, et al.
Publicado: (2019) -
Rapid assessment of SARS-CoV-2–evolved variants using virus-like particles
por: Syed, Abdullah M., et al.
Publicado: (2021) -
Using convalescent whole blood or plasma as passive immune therapy for the global war against Ebola
por: Lu, Shan
Publicado: (2014) -
Serosurveys and convalescent plasma in COVID-19
por: Pérez-Cameo, Cristina, et al.
Publicado: (2020)